Account
Inquiry
XCE Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist developed for research purposes in the field of metabolic disorders. This synthetic peptide analog shares structural similarities with human GLP-1 and has shown promising results in scientific studies related to glucose metabolism and weight management.
The XCE Semaglutide compound works by binding to and activating the GLP-1 receptor, which plays a crucial role in glucose-dependent insulin secretion. Research indicates this activation leads to enhanced insulin secretion while suppressing glucagon secretion in a glucose-dependent manner, making it particularly interesting for diabetes-related studies.
Our XCE Semaglutide is produced under strict quality control standards, ensuring high purity (99%) and consistent batch-to-batch quality. The product is supplied as a lyophilized powder in sterile vials, making it convenient for laboratory use.
Key research applications of XCE Semaglutide include: investigation of glucose metabolism mechanisms, study of pancreatic beta cell function, research into appetite regulation pathways, and exploration of potential cardiovascular effects related to GLP-1 receptor activation.
This product is intended for research purposes only and is not for human consumption. Proper laboratory safety protocols should always be followed when handling this material.
